Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-08-13
1987-05-19
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61U 3155
Patent
active
046669035
ABSTRACT:
Benzodiazepine antagonists are used to regenerate the sensitivity response to and prevent tolerance of benzodiazepine which otherwise develops during chronic benzodiazepine exposure. The administration of a plurality of time spaced doses of the antagonist also prevents benzodiazepine withdrawal symptoms. The preferred benzodiazepine antagonist is flumazepil.
REFERENCES:
Chem. Abst. 97-138502(Z), 104,176(F) & 174930(W), (1982).
Sandra E. File, "Recovery from Lorazepam Tolerance and the Effects of a Benzodiazepine Antagonist (RO 15-1788) on the Development of Tolerance," Psychopharmacology (1982) 77:284-288.
Scott E. Lukas, Roland R. Griffiths, "Precipitated Withdrawal by a Benzodiazepine Receptor Antagonist (RO 15-1788) After 7 Days of Diazepam", Science, vol. 217, 17 Sep. 1982.
L. F. McNicholas and W. R. Martin, "The Effect of a Benzodiazepine Antagonist, RO15-1788, In Diazepam Dependent Rats," Life Sciences, vol. 31, pp. 731-737.
R. J. Lamb and R. R. Griffiths, "Effects of Repeated Ro 15-1788 Administration in Benzodiazepine-Dependent Baboons", European Journal of Pharmacology, vol. 110, No. 2, pp. 257-261.
Friedman Stanley J.
Yale University
LandOfFree
Novel use of benzodiazepine antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel use of benzodiazepine antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel use of benzodiazepine antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1565026